{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:07:38Z","timestamp":1790363258843,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jtha.2024.08.006","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T12:55:27Z","timestamp":1725281727000},"page":"3322-3329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The use of direct oral anticoagulants in the secondary prevention of venous thromboembolism in patients with severe thrombophilia: communication from the ISTH SSC Subcommittee on Physiological Anticoagulants and Thrombophilia"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6676-0561","authenticated-orcid":false,"given":"Mirjana","family":"Kovac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Ignjatovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Bereczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.08.006_bib1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.08.006_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","article-title":"Extended use of dabigatran, warfarin, or placebo in venous thromboembolism","volume":"368","author":"Schulman","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.08.006_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1055\/s-0042-1753527","article-title":"Evolving knowledge on primary and secondary prevention of venous thromboembolism in carriers of hereditary thrombophilia: a narrative review","volume":"48","author":"Campello","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.08.006_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/jth.14398","article-title":"Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis","volume":"17","author":"Elsebaie","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.08.006_bib5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/1358863X16668588","article-title":"Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: findings from RE-COVER\u00ae, RE-COVER\u2122 II, and RE-MEDY","volume":"21","author":"Goldhaber","year":"2016","journal-title":"Vasc Med"},{"key":"10.1016\/j.jtha.2024.08.006_bib6","article-title":"Direct oral anticoagulants in patients with inherited thrombophilia and venous thromboembolism: a prospective cohort study","volume":"9","author":"Campello","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2024.08.006_bib7","first-page":"486","article-title":"Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study","volume":"18","author":"Margaglione","year":"2020","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtha.2024.08.006_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s11239-024-02957-4","article-title":"Outcomes of venous thromboembolism in patients with inherited thrombophilia treated with direct oral anticoagulants: insights from the RIETE registry","volume":"57","author":"Cohen","year":"2024","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.08.006_bib9","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2019.044","article-title":"Direct oral anticoagulants in patients affected by major congenital thrombophilia","volume":"11","author":"Serrao","year":"2019","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.jtha.2024.08.006_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12185-020-03012-7","article-title":"Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study","volume":"113","author":"Zuk","year":"2021","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtha.2024.08.006_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0040-1715647","article-title":"Direct oral anticoagulants in antithrombin deficiency: initial experience in a single center","volume":"121","author":"Bhoelan","year":"2021","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2024.08.006_bib12","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1182\/blood-2022-168179","article-title":"Hereditary antithrombin deficiency pilot project registry from the American Thrombosis and Hemostasis Network (ATHN) [abstract]","volume":"140","author":"DeSancho","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.006_bib13","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1160\/TH11-11-0788","article-title":"Dabigatran etexilate (Pradaxa\u00ae) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency","volume":"107","author":"Hermans","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.08.006_bib14","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/1060028014533304","article-title":"Rivaroxaban for the long-term treatment of spontaneous ovarian vein thrombosis caused by factor V Leiden homozygosity","volume":"48","author":"Cook","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jtha.2024.08.006_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.thromres.2014.01.023","article-title":"PROS1 mutations associated with protein S deficiency in Polish patients with residual vein obstruction on rivaroxaban therapy","volume":"134","author":"Wypasek","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.08.006_bib16","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.2169\/internalmedicine.55.7314","article-title":"Edoxaban was effective for the treatment of deep vein thrombosis and pulmonary thromboembolism in a cancer patient with antithrombin III deficiency","volume":"55","author":"Kawano","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.jtha.2024.08.006_bib17","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/MPH.0000000000000608","article-title":"Heparin-resistant thrombosis due to homozygous antithrombin deficiency treated with rivaroxaban: a case report","volume":"38","author":"Van Bruwaene","year":"2016","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtha.2024.08.006_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jccase.2017.06.008","article-title":"Successful treatment of a massive pulmonary embolism using rivaroxaban in a patient with antithrombin III deficiency","volume":"16","author":"Yamaguchi","year":"2017","journal-title":"J\u00a0Cardiol Cases"},{"key":"10.1016\/j.jtha.2024.08.006_bib19","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2169\/internalmedicine.0483-17","article-title":"Efficacy of oral factor Xa inhibitor for venous thromboembolism in a patient with antithrombin deficiency","volume":"57","author":"Minami","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.jtha.2024.08.006_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jccase.2018.12.007","article-title":"Efficacy and safety of apixaban in a patient with systemic venous thromboembolism associated with hereditary antithrombin deficiency","volume":"19","author":"Nojima","year":"2018","journal-title":"J\u00a0Cardiol Cases"},{"key":"10.1016\/j.jtha.2024.08.006_bib21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2169\/internalmedicine.2295-18","article-title":"Portal vein thrombosis in a patient with hereditary antithrombin deficiency","volume":"58","author":"Setaka","year":"2019","journal-title":"Intern Med"},{"key":"10.1016\/j.jtha.2024.08.006_bib22","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood.2019002927","article-title":"How I treat patients with hereditary antithrombin deficiency","volume":"134","author":"Pabinger","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.006_bib23","first-page":"182","article-title":"Recurrent venous thrombosis during direct oral anticoagulant therapy in a patient with protein S deficiency","volume":"66","author":"Yagi","year":"2019","journal-title":"J\u00a0Med Invest"},{"key":"10.1016\/j.jtha.2024.08.006_bib24","first-page":"1","article-title":"Successful treatment with rivaroxaban of an extended deep vein thrombosis complicated by pulmonary embolism in a patient with familial antithrombin III deficiency: a case report","volume":"4","author":"Appignani","year":"2019","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.jtha.2024.08.006_bib25","article-title":"The use of rivaroxaban for unprovoked pulmonary embolism in the setting of antithrombin deficiency","volume":"12","author":"Gryn","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jtha.2024.08.006_bib26","article-title":"Ilio-femoral venous thrombosis with hereditary antithrombin deficiency: a case report of rare thrombotic disease and successful treatment with catheter directed thrombolysis","volume":"5","author":"Miyashita","year":"2020","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.jtha.2024.08.006_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.thromres.2021.04.002","article-title":"Thrombotic storm under DOAC treatment in a patient with homozygous antithrombin Budapest III mutation","volume":"201","author":"Condoluci","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.08.006_bib28","first-page":"105","article-title":"Apixaban use in patients with protein C and S deficiency: a case series and review of literature","volume":"13","author":"Al Sulaiman","year":"2022","journal-title":"J\u00a0Blood Med"},{"issue":"Suppl 2","key":"10.1016\/j.jtha.2024.08.006_bib29","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.thromres.2012.02.024","article-title":"TFPI-dependent activities of protein S","volume":"129","author":"Peraramelli","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.08.006_bib30","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/jth.13665","article-title":"Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitor\u03b1, and protein S","volume":"15","author":"Dahlb\u00e4ck","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.08.006_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12512","article-title":"Reproductive issues in women on direct oral anticoagulants","volume":"5","author":"Beyer-Westendorf","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.08.006_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jth.14667","article-title":"Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH","volume":"18","author":"Cooper","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.08.006_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jth.15109","article-title":"Recommendations for clinical laboratory testing for protein S deficiency: communication from the SSC committee plasma coagulation inhibitors of the ISTH","volume":"19","author":"Marlar","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.08.006_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.14648","article-title":"Recommendations for clinical laboratory testing for antithrombin deficiency; communication from the SSC of the ISTH","volume":"18","author":"Van Cott","year":"2020","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:58:05Z","timestamp":1762030685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624004926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1538783624004926"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.08.006","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of direct oral anticoagulants in the secondary prevention of venous thromboembolism in patients with severe thrombophilia: communication from the ISTH SSC Subcommittee on Physiological Anticoagulants and Thrombophilia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}